IDEX Q2 Earnings Call Highlights
IDEX reported second-quarter 2026 results that exceeded its expectations, driven by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.
Why it matters — The raised full-year outlook across multiple financial metrics signals improving operational momentum and stronger-than-anticipated demand in a key segment.